in a double-blind , crossover trial a controlled-release multiple-units indomethacin formulation ( 50 mg twice daily ) was compared with conventional capsules ( 25 mg twice daily with 50 mg in the evening ) in 12 young and 18 elderly in-patients with rheumatoid arthritis .
C0021246
indomethacin
C0003873
rheumatoid arthritis